1309682-26-5

Basic information

• Product Name: 4-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2-fluorobenzoic acid
• Synonyms: 4-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2-fluorobenzoic acid
• CAS NO: 1309682-26-5
• Molecular Weight: 272.238
• Mol File: 1309682-26-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2-fluorobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2-fluorobenzoic acid(1309682-26-5)
• EPA Substance Registry System: 4-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2-fluorobenzoic acid(1309682-26-5)

Safety Data

• Hazardous Substances Data: 1309682-26-5(Hazardous Substances Data)

Upstream product

• 1010120-60-1 ethyl [(5-bromopyridin-2-yl)carbamothioyl]carbamate 
• 120153-08-4 4-(dihydroxyboranyl)-2-fluorobenzoic acid 
• 947248-68-2 6-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine 
• 1072-97-5 5-bromo-2-pyridylamine 

Downstream Products

• 1309682-27-6 4-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2-fluoro-N-(2,2,2-trifluoroethyl)benzamide 
• 1352620-84-8 4-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2-fluoro-N-(4-fluorobenzyl)-benzamide 

Relevant articles and documents

TRIAZOLOPYRIDINES

The present invention relates to triazolopyridine compounds of general formula (I) : in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said com

TRIAZOLOPYRIDINE DERIVATIVES

The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of proliferative diseases, as well as to intermediate compounds useful in the preparation of said compounds.